ArticleReproductive health2026
Hormonal contraception and hemoglobin levels in urban Malawi: a longitudinal analysis.
Article in Reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundStudies have highlighted potential non-contraceptive benefits from women’s use of hormonal, reversible contraceptive methods. Given the physiological pathways through which hormonal contraception may interact with menstruation, a growing body of work has documented the extent to which hormonal method use might be associated with increased hemoglobin levels and reductions in the risk of anemia in women. While these findings are promising, the scope for causal inference from these studies is restricted by their cross-sectional design, which limits the extent to which bias from individual-level confounding can be mitigated.
methodsWe leverage three years of annual, woman-level panel data from a randomized controlled trial for 2143 women from urban Malawi to assess the relationship between women’s use of hormonal contraception and their risk of anemia, controlling for individual woman fixed effects. We compare our panel results with standard cross-sectional estimates from the same sample.
resultsWe find that hormonal method use is associated with increased levels of hemoglobin in women, though the effects are different for different hormonal methods. Adoption of an injectable is associated with a 3.7 g/cL increase, and adoption of an implant a 5.7 g/cL increase, in hemoglobin levels. Our estimates are consistent across cross-sectional and panel model specifications, suggesting that existing cross-sectional estimates may be reliable.
conclusionsOur findings highlight potential health benefits from hormonal contraceptive use that extend beyond pregnancy prevention. These benefits, in turn, have significant implications as to how women are counseled on contraception both within family planning and nutrition programs.
trial registrationThis trial was registered at the American Economics Association Registry for randomized controlled trials on May 7, 2015 (AEARCTR-0000697) and at the Registry for International Development Impact Evaluations (RIDIE) on May 28, 2015 (RIDIE-STUDY-ID-556784ed86956).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.